Tryptophan Synthase
Subunits: Beta Subunit, Alpha Subunit with PLP, IGP
Identifiers
EC number	4.2.1.20
CAS number	9014-52-2
Databases
IntEnz	IntEnz view
BRENDA	BRENDA entry
ExPASy	NiceZyme view
KEGG	KEGG entry
MetaCyc	metabolic pathway
PRIAM	profile
PDB structures	RCSB PDB PDBe PDBsum
Gene Ontology	AmiGO / QuickGO
Search PMC articles PubMed articles NCBI proteins

Tryptophan synthase or tryptophan synthetase is an enzyme that catalyzes the final two steps in the biosynthesis of tryptophan.^[1] It is commonly found in Eubacteria,^[2]Archaebacteria,^[3]Protista,^[4]Fungi,^[5] and Plantae.^[6] However, it is absent from Animalia.^[7] It is typically found as an α2β2 tetramer. The α subunits catalyze the reversible formation of indole and glyceraldehyde-3-phosphate (G3P) from indole-3-glycerol phosphate (IGP). The β subunits catalyze the irreversible condensation of indole and serine to form tryptophan in a pyridoxal phosphate (PLP) dependent reaction. Each α active site is connected to a β active site by a 25 angstrom long hydrophobic channel contained within the enzyme. This facilitates the diffusion of indole formed at α active sites directly to β active sites in a process known as substrate channeling.^[8] The active sites of tryptophan synthase are allosterically coupled.^[9]

Enzyme structure[edit]

Subunits: Tryptophan synthase typically exists as an α-ββ-α complex. The α and β subunits have molecular masses of 27 and 43 kDa respectively. The α subunit has a TIM barrel conformation. The β subunit has a fold type II conformation and a binding site adjacent to the active site for monovalent cations.^[10] Their assembly into a complex leads to structural changes in both subunits resulting in reciprocal activation. There are two main mechanisms for intersubunit communication. First, the COMM domain of the β-subunit and the α-loop2 of the α-subunit interact. Additionally, there are interactions between the αGly181 and βSer178 residues.^[11] The active sites are regulated allosterically and undergo transitions between open, inactive, and closed, active, states.^[9]

Indole-3-glycerol binding site: See image 1.

Indole and serine binding site: See image 1.

Hydrophobic channel: The α and β active sites are separated by a 25 angstrom long hydrophobic channel contained within the enzyme allowing for the diffusion of indole. If the channel did not exist, the indole formed at an α active site would quickly diffuse away and be lost to the cell as it is hydrophobic and can easily cross membranes. As such, the channel is essential for enzyme complex function.^[12]

Image 2: Proposed mechanism of tryptophan synthase

Enzyme mechanism[edit]

α subunit reaction: The α subunit catalyzes the formation of indole and G3P from a retro-aldol cleavage of IGP. The αGlu49 and αAsp60 are thought to be directly involved in the catalysis as shown.^[8] The rate limiting step is the isomerization of IGP.^[13] See image 2.

β subunit reaction: The β subunit catalyzes the β-replacement reaction in which indole and serine condense to form tryptophan in a PLP dependent reaction. The βLys87, βGlu109, and βSer377 are thought to be directly involved in the catalysis as shown.^[8] Again, the exact mechanism has not been conclusively determined. See image 2.

Net reaction: See image 3.

Image 3: Reaction catalyzed by tryptophan synthase

Image 1: Active sites for α and β subunits showing hypothesized catalytic residues

Biological function[edit]

Tryptophan synthase is commonly found in Eubacteria, Archaebacteria, Protista, Fungi, and Plantae. It is absent from animals such as humans. Tryptophan is one of the twenty standard amino acids and one of nine essential amino acids for humans. As such, tryptophan is a necessary component of the human diet.

Substrate scope[edit]

Tryptophan synthetase is also known to accept indole analogues, e.g., fluorinated or methylated indoles, as substrates, generating the corresponding tryptophan analogues.^[14]

Disease relevance[edit]

As humans do not have tryptophan synthase, this enzyme has been explored as a potential drug target.^[15] However, it is thought that bacteria have alternate mechanisms to produce amino acids which might make this approach less effective. In either case, even if the drug only weakens bacteria, it might still be useful as the bacteria are already vulnerable in the hostile host environment. As such, the inhibition of tryptophan synthase along with other PLP-enzymes in amino acid metabolism has the potential to help solve medical problems.^[16]

Inhibition of tryptophan synthase and other PLP-enzymes in amino acid metabolism has been suggested for:

• Treatment of tuberculosis^[15]
  


• Treatment of ocular and genital infections^[17]
  


• Treatment of cryptosporidiosis^[15]
  


• 
  Herbicide use^[18]
  

Evolution[edit]

It is thought that early in evolution the trpB2 gene was duplicated. One copy entered the trp operon as trpB2i allowing for its expression with trpA. TrpB2i formed transient complexes with TrpA and in the process activated TrpA unidirectionally. The other copy remained outside as trpB2o, and fulfilled an existing role or played a new one such as acting as a salvage protein for indole. TrpB2i evolved into TrpB1, which formed permanent complexes with trpA resulting in bidirectional activation. The advantage of the indole salvage protein declined and the TrpB gene was lost. Finally, the TrpB1 and TrpA genes were fused resulting in the formation the bifunctional enzyme.^[19]

Historical significance[edit]

Tryptophan synthase was the first enzyme identified that had two catalytic capabilities that were extensively studied. It was also the first identified to utilize substrate channeling. As such, this enzyme has been studied extensively and is the subject of great interest.^[8]

See also[edit]

• Lyase


• Synthase


• Tryptophan synthase (indole-salvaging)

References[edit]